Methods in Mammalian Autophagy Research
By N. Mizushima, Tamotsu Yoshimorim, Beth Levine. Cell, 2010
4,443 citations recorded by the source corpus.
Autophagy has been implicated in many physiological and pathological processes. Accordingly, there is a growing scientific need to accurately identify, quantify, and manipulate the process of autophagy in cells. However, as autophagy involves dynamic and complicated processes, it is often analyzed incorrectly. In this Primer, we discuss methods to monitor autophagy and to modulate autophagic activity, with a primary focus on mammalian macroautophagy.
Subfields: Epidemiology, Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/d7ea336922250ee7c7af24f42f6c24a27b495b25
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Guido Kroemer
- Beth Levine
- I. Slaninová
- L. Galluzzi
- Douglas R. Green
- N. Mizushima
- Alec C. Kimmelman
- Guillermo Mariño
In Pharmacology
- Guido Kroemer
- Beth Levine
- Alec C. Kimmelman
- Douglas R. Green
- L. Galluzzi
- N. Mizushima
- Guillermo Mariño
- D. Rubinsztein
In Physiology
- Guido Kroemer
- Beth Levine
- Alec C. Kimmelman
- L. Galluzzi
- Douglas R. Green
- N. Mizushima
- D. Rubinsztein
- Guillermo Mariño
Citations in the corpus
- Autophagy in immunity and inflammation (2011, background): “Autophagy is a general term for pathways by which cytoplasmic material, including soluble macromolecules and organelles, is delivered to lysosomes for degradation 6 .”
- Activation of Autophagy by Inflammatory Signals Limits IL-1β Production by Targeting Ubiquitinated Inflammasomes for Destruction (2012, neutral): “Addition of the PI(3)K inhibitor 3-methyladenine (3-MA), which is known to block autophagosome formatio”
- The dynamic nature of autophagy in cancer. (2011, methodology): “The measurement of autophagy has been a topic of intense discussion, and there are several comprehensive reviews on the subject as well a variety of published guidelines (Mizushima 2004; Klionsky et al. 2008; Mizushima et al. 2010).”
- Monitoring and Measuring Autophagy (2017, background): “Also, LC3-II can ectopically localize on non-autophagosome structures that are not turned over in the lysosome [8,15,32].”
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 (2011, background): “pitfalls of these techniques is beyond the scope of this article, and several excellent reviews on methods for monitoring the autophagic flux have recently been published.(15,98,99) Nevertheless, it should be remembered that steady-state methods do not provide any reliable estimation of autophagic a”
- Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis (2019, background): “Chaperone-mediated autophagy involves the direct translocation of cytosolic proteins across the lysosomal membrane while microautophagy involves inward invagination of lysosomal membrane delivering a small portion of cytoplasm into the lysosomal lumen [82].”
- p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation (2016, neutral): “p62 is widely used as a predictor of autophagic flux [2, 61], since it is a thoroughly explored autophagic substrate.”
- Autophagy as a target for anticancer therapy (2011, background): “However, LC3 fluorescence microscopy suffers from subjectivity when analyzing results”
- PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity (2012, background): “mitochondria, peroxisomes, and endoplasmic reticulum) are degraded by the lysosome (8, 9).”
- Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control (2014, methodology): “We then incubated these HeLa cells with antimycin A in the presence of the V-ATPase inhibitor bafilomycin A1 or the lysosomal hydrolase inhibitors pepstatin A and E64d, inhibitors commonly used in the study of the lysosomal degradative pathway (Mizushima et al, 2010; Klionsky et al, 2012).”
- Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy (2020, background): “To understand these discrepancies, it is important to note that autophagy involves dynamic and complicated processes, and it has been a challenge in autophagy research to capture a dynamic process with static measurements [66].”